- 5-fluorourasil CHEMBL185 5-Fluorouracil Fluracil Ro-2-9757 5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil) 5-fluorouacil 5 fluorouracil 5-Fluoro-1H-pyrimidine-2,4-dione(5-FU) 5-fluoropyrimidine-2,4(1H,3H)-dione Carac 5-Fluoro-1H-pyrimidine-2,4-dione (5-FU) 5-Fluoro-1H-pyrimidine-2,4-dione(5FU) Efudex (5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione Adrucil 5-fluoro-uracil Fluoroplex 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU) 5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra) 5-Fluoro-1H-pyrimidine-2,4-dione 5F-uracil 5-Florouracil FLUOROURACIL, 5- 5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil) BDBM50340677 5-FU
- BDBM173609 1-[3'-[4-[(Adenine-9-yl)methyl]-1,2,3-triazol-1-yl]-b-D-ribofuranosyl]5-fluorouracil (5c)
- BMS-205603-01 Lamivudine impurity e SQ-7726 NSC-3970 BDBM50549809 CHEBI:17568 Fluorouracil specified compound c Hybar x SQ-8493 Lamivudine impurity e rs SQ-6201 Uracil Pyrod
- 5-fluoro-2'-Deoxy-uridine BDBM50340678 FLOXURIDINE 1-(beta-D-2-deoxy-erythro-pentofuranosyl)-5-fluorouracil 5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione 5-fluoro-2'-deoxyuridine 2'-deoxy-5-fluorouridine Fluoruridine Deoxyribose 5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione FUDR 5-Fluoro-1-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione 5-Fluoro-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione CHEMBL917
- Jiang, Y; Li, X; Hou, J; Huang, Y; Wang, X; Jia, Y; Wang, Q; Xu, W; Zhang, J; Zhang, Y Synthesis and biological characterization of ubenimex-fluorouracil conjugates for anti-cancer therapy. Eur J Med Chem 143: 334-347 (2018)
- Jiang, Y; Li, X; Hou, J; Huang, Y; Jia, Y; Zou, M; Zhang, J; Wang, X; Xu, W; Zhang, Y Discovery of BC-01, a novel mutual prodrug (hybrid drug) of ubenimex and fluorouracil as anticancer agent. Eur J Med Chem 121: 649-657 (2016)
- Luo, D; Guo, Z; Zhao, X; Wu, L; Liu, X; Zhang, Y; Zhang, Y; Deng, Z; Qu, X; Cui, S; Wan, S Novel 5-fluorouracil sensitizers for colorectal cancer therapy: Design and synthesis of S1P receptor 2 (S1PR2) antagonists. Eur J Med Chem 227: (2022)
- Tzioumaki, N; Manta, S; Tsoukala, E; Vande Voorde, J; Liekens, S; Komiotis, D; Balzarini, J Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: novel 5-fluorouracil analogs that target thymidylate synthase. Eur J Med Chem 46: 993-1005 (2011)
- Renck, D; Machado, P; Souto, AA; Rosado, LA; Erig, T; Campos, MM; Farias, CB; Roesler, R; Timmers, LF; de Souza, ON; Santos, DS; Basso, LA Design of novel potent inhibitors of human uridine phosphorylase-1: synthesis, inhibition studies, thermodynamics, and in vitro influence on 5-fluorouracil cytotoxicity. J Med Chem 56: 8892-902 (2013)
- Narayan, S; Ramisetti, S; Jaiswal, AS; Law, BK; Singh-Pillay, A; Singh, P; Amin, S; Sharma, AK ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. Eur J Med Chem 161: 456-467 (2019)
- Nakayama, C; Wataya, Y; Santi, DV; Saneyoshi, M; Ueda, T Interaction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil. J Med Chem 24: 1161-5 (1982)
- Petreni, A; Bonardi, A; Lomelino, C; Osman, SM; ALOthman, ZA; Eldehna, WM; El-Haggar, R; McKenna, R; Nocentini, A; Supuran, CT Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells. Eur J Med Chem 190: (2020)